Cargando…

When is a randomised controlled trial health equity relevant? Development and validation of a conceptual framework

BACKGROUND: Randomised controlled trials can provide evidence relevant to assessing the equity impact of an intervention, but such information is often poorly reported. We describe a conceptual framework to identify health equity-relevant randomised trials with the aim of improving the design and re...

Descripción completa

Detalles Bibliográficos
Autores principales: Jull, J, Whitehead, M, Petticrew, M, Kristjansson, E, Gough, D, Petkovic, J, Volmink, J, Weijer, C, Taljaard, M, Edwards, S, Mbuagbaw, L, Cookson, R, McGowan, J, Lyddiatt, A, Boyer, Y, Cuervo, L G, Armstrong, R, White, H, Yoganathan, M, Pantoja, T, Shea, B, Pottie, K, Norheim, O, Baird, S, Robberstad, B, Sommerfelt, H, Asada, Y, Wells, G, Tugwell, P, Welch, V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623521/
https://www.ncbi.nlm.nih.gov/pubmed/28951402
http://dx.doi.org/10.1136/bmjopen-2016-015815
_version_ 1783268107196825600
author Jull, J
Whitehead, M
Petticrew, M
Kristjansson, E
Gough, D
Petkovic, J
Volmink, J
Weijer, C
Taljaard, M
Edwards, S
Mbuagbaw, L
Cookson, R
McGowan, J
Lyddiatt, A
Boyer, Y
Cuervo, L G
Armstrong, R
White, H
Yoganathan, M
Pantoja, T
Shea, B
Pottie, K
Norheim, O
Baird, S
Robberstad, B
Sommerfelt, H
Asada, Y
Wells, G
Tugwell, P
Welch, V
author_facet Jull, J
Whitehead, M
Petticrew, M
Kristjansson, E
Gough, D
Petkovic, J
Volmink, J
Weijer, C
Taljaard, M
Edwards, S
Mbuagbaw, L
Cookson, R
McGowan, J
Lyddiatt, A
Boyer, Y
Cuervo, L G
Armstrong, R
White, H
Yoganathan, M
Pantoja, T
Shea, B
Pottie, K
Norheim, O
Baird, S
Robberstad, B
Sommerfelt, H
Asada, Y
Wells, G
Tugwell, P
Welch, V
author_sort Jull, J
collection PubMed
description BACKGROUND: Randomised controlled trials can provide evidence relevant to assessing the equity impact of an intervention, but such information is often poorly reported. We describe a conceptual framework to identify health equity-relevant randomised trials with the aim of improving the design and reporting of such trials. METHODS: An interdisciplinary and international research team engaged in an iterative consensus building process to develop and refine the conceptual framework via face-to-face meetings, teleconferences and email correspondence, including findings from a validation exercise whereby two independent reviewers used the emerging framework to classify a sample of randomised trials. RESULTS: A randomised trial can usefully be classified as ‘health equity relevant’ if it assesses the effects of an intervention on the health or its determinants of either individuals or a population who experience ill health due to disadvantage defined across one or more social determinants of health. Health equity-relevant randomised trials can either exclusively focus on a single population or collect data potentially useful for assessing differential effects of the intervention across multiple populations experiencing different levels or types of social disadvantage. Trials that are not classified as ‘health equity relevant’ may nevertheless provide information that is indirectly relevant to assessing equity impact, including information about individual level variation unrelated to social disadvantage and potentially useful in secondary modelling studies. CONCLUSION: The conceptual framework may be used to design and report randomised trials. The framework could also be used for other study designs to contribute to the evidence base for improved health equity.
format Online
Article
Text
id pubmed-5623521
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-56235212017-10-10 When is a randomised controlled trial health equity relevant? Development and validation of a conceptual framework Jull, J Whitehead, M Petticrew, M Kristjansson, E Gough, D Petkovic, J Volmink, J Weijer, C Taljaard, M Edwards, S Mbuagbaw, L Cookson, R McGowan, J Lyddiatt, A Boyer, Y Cuervo, L G Armstrong, R White, H Yoganathan, M Pantoja, T Shea, B Pottie, K Norheim, O Baird, S Robberstad, B Sommerfelt, H Asada, Y Wells, G Tugwell, P Welch, V BMJ Open Patient-Centred Medicine BACKGROUND: Randomised controlled trials can provide evidence relevant to assessing the equity impact of an intervention, but such information is often poorly reported. We describe a conceptual framework to identify health equity-relevant randomised trials with the aim of improving the design and reporting of such trials. METHODS: An interdisciplinary and international research team engaged in an iterative consensus building process to develop and refine the conceptual framework via face-to-face meetings, teleconferences and email correspondence, including findings from a validation exercise whereby two independent reviewers used the emerging framework to classify a sample of randomised trials. RESULTS: A randomised trial can usefully be classified as ‘health equity relevant’ if it assesses the effects of an intervention on the health or its determinants of either individuals or a population who experience ill health due to disadvantage defined across one or more social determinants of health. Health equity-relevant randomised trials can either exclusively focus on a single population or collect data potentially useful for assessing differential effects of the intervention across multiple populations experiencing different levels or types of social disadvantage. Trials that are not classified as ‘health equity relevant’ may nevertheless provide information that is indirectly relevant to assessing equity impact, including information about individual level variation unrelated to social disadvantage and potentially useful in secondary modelling studies. CONCLUSION: The conceptual framework may be used to design and report randomised trials. The framework could also be used for other study designs to contribute to the evidence base for improved health equity. BMJ Publishing Group 2017-09-25 /pmc/articles/PMC5623521/ /pubmed/28951402 http://dx.doi.org/10.1136/bmjopen-2016-015815 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Patient-Centred Medicine
Jull, J
Whitehead, M
Petticrew, M
Kristjansson, E
Gough, D
Petkovic, J
Volmink, J
Weijer, C
Taljaard, M
Edwards, S
Mbuagbaw, L
Cookson, R
McGowan, J
Lyddiatt, A
Boyer, Y
Cuervo, L G
Armstrong, R
White, H
Yoganathan, M
Pantoja, T
Shea, B
Pottie, K
Norheim, O
Baird, S
Robberstad, B
Sommerfelt, H
Asada, Y
Wells, G
Tugwell, P
Welch, V
When is a randomised controlled trial health equity relevant? Development and validation of a conceptual framework
title When is a randomised controlled trial health equity relevant? Development and validation of a conceptual framework
title_full When is a randomised controlled trial health equity relevant? Development and validation of a conceptual framework
title_fullStr When is a randomised controlled trial health equity relevant? Development and validation of a conceptual framework
title_full_unstemmed When is a randomised controlled trial health equity relevant? Development and validation of a conceptual framework
title_short When is a randomised controlled trial health equity relevant? Development and validation of a conceptual framework
title_sort when is a randomised controlled trial health equity relevant? development and validation of a conceptual framework
topic Patient-Centred Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623521/
https://www.ncbi.nlm.nih.gov/pubmed/28951402
http://dx.doi.org/10.1136/bmjopen-2016-015815
work_keys_str_mv AT jullj whenisarandomisedcontrolledtrialhealthequityrelevantdevelopmentandvalidationofaconceptualframework
AT whiteheadm whenisarandomisedcontrolledtrialhealthequityrelevantdevelopmentandvalidationofaconceptualframework
AT petticrewm whenisarandomisedcontrolledtrialhealthequityrelevantdevelopmentandvalidationofaconceptualframework
AT kristjanssone whenisarandomisedcontrolledtrialhealthequityrelevantdevelopmentandvalidationofaconceptualframework
AT goughd whenisarandomisedcontrolledtrialhealthequityrelevantdevelopmentandvalidationofaconceptualframework
AT petkovicj whenisarandomisedcontrolledtrialhealthequityrelevantdevelopmentandvalidationofaconceptualframework
AT volminkj whenisarandomisedcontrolledtrialhealthequityrelevantdevelopmentandvalidationofaconceptualframework
AT weijerc whenisarandomisedcontrolledtrialhealthequityrelevantdevelopmentandvalidationofaconceptualframework
AT taljaardm whenisarandomisedcontrolledtrialhealthequityrelevantdevelopmentandvalidationofaconceptualframework
AT edwardss whenisarandomisedcontrolledtrialhealthequityrelevantdevelopmentandvalidationofaconceptualframework
AT mbuagbawl whenisarandomisedcontrolledtrialhealthequityrelevantdevelopmentandvalidationofaconceptualframework
AT cooksonr whenisarandomisedcontrolledtrialhealthequityrelevantdevelopmentandvalidationofaconceptualframework
AT mcgowanj whenisarandomisedcontrolledtrialhealthequityrelevantdevelopmentandvalidationofaconceptualframework
AT lyddiatta whenisarandomisedcontrolledtrialhealthequityrelevantdevelopmentandvalidationofaconceptualframework
AT boyery whenisarandomisedcontrolledtrialhealthequityrelevantdevelopmentandvalidationofaconceptualframework
AT cuervolg whenisarandomisedcontrolledtrialhealthequityrelevantdevelopmentandvalidationofaconceptualframework
AT armstrongr whenisarandomisedcontrolledtrialhealthequityrelevantdevelopmentandvalidationofaconceptualframework
AT whiteh whenisarandomisedcontrolledtrialhealthequityrelevantdevelopmentandvalidationofaconceptualframework
AT yoganathanm whenisarandomisedcontrolledtrialhealthequityrelevantdevelopmentandvalidationofaconceptualframework
AT pantojat whenisarandomisedcontrolledtrialhealthequityrelevantdevelopmentandvalidationofaconceptualframework
AT sheab whenisarandomisedcontrolledtrialhealthequityrelevantdevelopmentandvalidationofaconceptualframework
AT pottiek whenisarandomisedcontrolledtrialhealthequityrelevantdevelopmentandvalidationofaconceptualframework
AT norheimo whenisarandomisedcontrolledtrialhealthequityrelevantdevelopmentandvalidationofaconceptualframework
AT bairds whenisarandomisedcontrolledtrialhealthequityrelevantdevelopmentandvalidationofaconceptualframework
AT robberstadb whenisarandomisedcontrolledtrialhealthequityrelevantdevelopmentandvalidationofaconceptualframework
AT sommerfelth whenisarandomisedcontrolledtrialhealthequityrelevantdevelopmentandvalidationofaconceptualframework
AT asaday whenisarandomisedcontrolledtrialhealthequityrelevantdevelopmentandvalidationofaconceptualframework
AT wellsg whenisarandomisedcontrolledtrialhealthequityrelevantdevelopmentandvalidationofaconceptualframework
AT tugwellp whenisarandomisedcontrolledtrialhealthequityrelevantdevelopmentandvalidationofaconceptualframework
AT welchv whenisarandomisedcontrolledtrialhealthequityrelevantdevelopmentandvalidationofaconceptualframework